SHELLEY VELICKOFF: Open Payments
NPI 1811246531 · WEST LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,248 in 88 payments from 11 companies in 2025. Trend: 2023 $1,130 · 2024 $1,040 · 2025 $1,248
Food & beverage: $1,093Education: $155
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $542 |
| Novartis Pharmaceuticals Corporation | 22 | $182 |
| ABBVIE INC. | 22 | $171 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| GENZYME CORPORATION | 2 | $54 |
| Galderma Laboratories, L.P. | 2 | $51 |
| UCB, Inc. | 2 | $46 |
| Lilly USA, LLC | 1 | $25 |
| Amgen Inc. | 1 | $16 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, COSENTYX, Sotyktu, NEMLUVIO, Bimzelx, RINVOQ.
Industry payments across IN — which companies pay providers there.
